HAYA Therapeutics SA


HAYA Therapeutics is a Switzerland-based pre-clinical stage biopharmaceutical company dedicated to treating heart failure through the discovery and development of targeted first-in-class RNA-based therapeutics, with a specific focus on long noncoding RNA targets. Our vision is to be the first company and a world leader in translating long noncoding RNA (lncRNA) discoveries into breakthrough therapies to monitor and treat heart failure patients.